[Progress observations in patients with inoperable lung tumors during treatment with a combined internal therapy (alkylating agent and endogenous polypeptid)].
D000477:Alkylating Agents / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D011379:Prognosis; D014228:Triaziquone / Q000627:therapeutic use
D000477:Alkylating Agents; D010455:Peptides; D003520:Cyclophosphamide; D014228:Triaziquone
Verlaufsbeobachtungen bei Kranken mit inoperablen Lungentumoren bei Behandlung mit kombinierter interner Therapie (alkylierende Substanz und körpereigenes Polypeptid)